BioLife Solutions Inc. (BLFS) is a publicly traded Healthcare sector company. As of August 15, 2026, BLFS trades at $35.28 with a market cap of $1.71B and a P/E ratio of -390.66. BLFS moved -0.53% today. Year to date, BLFS is +46.80%; over the trailing twelve months it is +38.51%. Its 52-week range spans $17.86 to $35.35. Analyst consensus is neutral with an average price target of $31.00. Rallies surfaces BLFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioLife Solutions Inc. (BLFS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BLFS moved -0.53% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $35.28 |
| Market Cap | $1.71B |
| P/E Ratio | -390.66 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.35 |
| 52-Week Low | $17.86 |
| Volume | 436.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $96.21M |
| Net Income | $-4.59M |
| Gross Margin | 64.56% |
7 analysts cover BLFS: 0 strong buy, 0 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $31.00.